The dramatic early rise in IL-10 – canonically classified as an anti-inflammatory cytokine – appears to be a distinguishing feature of hyperinflammation during severe SARS-CoV-2 infection (6) and several studies indicate that IL-10 levels predict poor outcomes in patients with COVID-19 (7, 8). The gene discussed is IL10; the disease is COVID-19.